Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2&lt;sup&gt;nd&lt;/sup&gt; line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
Onkogematologiâ